Carregant...
Treatment of Bone Fragility in Patients with Diabetes: Antiresorptive versus Anabolic?
PURPOSE OF REVIEW: The pathogenesis of bone fragility in diabetes has not been fully characterized. The anti-fracture efficacy of available therapies remains unproven in patients with diabetes. We aim to collate current evidence of the treatment of diabetic bone fragility, and to provide a rationale...
Guardat en:
| Publicat a: | Curr Opin Endocrinol Diabetes Obes |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8244995/ https://ncbi.nlm.nih.gov/pubmed/34010225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000645 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|